companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2024
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -242,054 and a net result of DKK 2,080,087 compared with DKK -7,687 the year before. Equity amounted to DKK 3,546,845. The solvency ratio was 98.8%.
- Gross Profit
- -242,054 kr.
- Profit/Loss
- 2,080,087 kr.
- Equity
- 3,546,845 kr.
- Total Assets
- 3,588,156 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -242 t. | 2.1 mio. | 3.5 mio. | - |
| 2023 | - | 49 t. | -8 t. | 1.5 mio. | - |
| 2022 | - | -20 t. | -1 mio. | 1.5 mio. | 0 |
| 2021 | - | -15 t. | -168 t. | 2.5 mio. | 0 |
| 2020 | - | -16 t. | -55 t. | 2.7 mio. | - |
How creditworthy is NORDIC BIOTECH PRIVATE INVESTORS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2023. Gross profit came to DKK 49,468, and the net result was DKK -7,687.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.